BC

Broadfin Capital Portfolio holdings

AUM $403M
1-Year Est. Return 100.56%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+100.56%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$485M
AUM Growth
-$72.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
58
New
Increased
Reduced
Closed

Top Buys

1
+$33.1M
2
+$19.8M
3
+$19.4M
4
ADMS
Adamas Pharmaceuticals
ADMS
+$16.7M
5
TSRO
TESARO, Inc.
TSRO
+$16.2M

Top Sells

1
+$22.5M
2
+$17.1M
3
+$13.5M
4
XENE icon
Xenon Pharmaceuticals
XENE
+$11.8M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$8.04M

Sector Composition

1 Healthcare 87.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$5.71M 1.18%
+58,700
27
$5.65M 1.16%
217,136
-1,000
28
$5.26M 1.08%
866,500
+616,500
29
$5.1M 1.05%
84,770
30
$4.78M 0.99%
+129,300
31
$4.67M 0.96%
51,000
32
$4.41M 0.91%
+47,373
33
$4.32M 0.89%
+2,618,819
34
$4.1M 0.84%
+528,571
35
$3.87M 0.8%
282,338
-22,947
36
$3.38M 0.7%
89,100
-483,979
37
$3.31M 0.68%
190,000
+57,400
38
$3.09M 0.64%
119,294
-171,919
39
$2.83M 0.58%
143,129
-6,871
40
$2.67M 0.55%
+351,800
41
$1.66M 0.34%
6,789
-140
42
$1.46M 0.3%
+4,777
43
$1.35M 0.28%
28,652
-8,405
44
$1.03M 0.21%
1,229,301
-719,253
45
$1.03M 0.21%
449,585
-220,227
46
– –
-62,200
47
– –
0
48
– –
-289,035
49
– –
0
50
– –
-2,493,021
1
2
3